Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE RAGE appears to be an important regulator of inflammatory, stress and survival pathways that lead to carcinogenesis, resistance to chemotherapy, enhanced proliferation and the high metastatic potential of pancreatic cancer. 29998364 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 AlteredExpression disease BEFREE In conclusion, the results demonstrated that the molecular mechanisms of quercetin in regulating apoptosis and autophagy-related pathways and increasing GEM chemosensitivity in pancreatic cancer cells involved inhibition of RAGE expression. 31590760 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. 29573228 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE Exogenous AGE administration to PaC-prone mice induced RAGE upregulation in pancreatic intraepithelial neoplasias (PanINs) and markedly accelerated progression to invasive PaC. 29533466 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE The engagement of RAGE turns out to an establishment of numerous intracellular signalling mechanisms resulting in the progression and perpetuation of many types of cancer including, the pancreatic cancer. 28811077 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE RAGE-specific single chain Fv for PET imaging of pancreatic cancer. 29529089 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 AlteredExpression disease BEFREE RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer. 28867179 2017
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. 25908451 2015
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.090 Biomarker disease BEFREE Soluble RAGE is decreased in patients with PC compared to patients with DM and controls (975+/-532 vs. 1416+/-868 vs. 1723+/-643pg/mL, p<0.001). 20398646 2010